Background and Aim: Previous research studies have shown that poorly controlled type 2 diabetes patients do not receive insulin therapy because of the resistance of the patients to insulin prescription. This study aimed to assess the belief of Caribbean insulin-naive type 2 diabetes patients on insulin therapy.

Methods: We recruited 510 insulin-naive type 2 diabetes patients who have had diabetes for at least five years for a questionnaire interview. The questionnaire was a modified version of a validated research questionnaire previously used by other researchers. Data collected was analysed with SPSS software using chi-square to test for significances.

Results: The majority of the patients were females, of East Indian descent, have had diabetes for more than 10 years and take more than two different diabetes medications daily. About 67% and 81% of the patients do not believe that insulin therapy will cause them hypoglycaemia and weight gain respectively. Similarly, a significant percent do not believe that taking insulin will interfere with their normal lifestyle activities (72.2%, p=0.048). Although, a majority (64%) of the patients believe that taking insulin translates to personal failure in optimal blood glucose control, an overwhelming percent (90%) do not believe that taking insulin will cause people to treat them differently. Whereas a majority of the patients do not believe that taking insulin will be helpful in preventing long-term diabetes complications (63.9%, p=0.001), 51% thought that switching to insulin therapy would make them feel better within six months.

Conclusion: Contrary to several reports, this study shows that insulin-naïve Caribbean type 2 diabetes patients do not have a significant negative perception towards insulin therapy. This finding might be related to the socio-cultural background of the patients studied.

Disclosure

C.E. Ezenwaka: None. P.C. Onuoha: None. R. Extavour: None. S.S. Yearwood: None.

Funding

University of the West Indies at St. Augustine

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.